Biotech Stock Roundup: CGEN Up on GILD Deal, MRNA Gains on Study Data & More
https://www.zacks.com/stock/news/2201158/biotech-stock-roundup-cgen-up-on-gild-deal-mrna-gains-on-study-data-more?cid=CS-ZC-FT-analyst_blog|stock_roundup-2201158
Dec 21, 2023 - Compugen (CGEN) and Moderna (MRNA) are in the news on collaboration and study updates, respectively.
0
Gilead (GILD), Compugen Collaborate for Immunotherapy Program
https://www.zacks.com/stock/news/2200585/gilead-gild-compugen-collaborate-for-immunotherapy-program?cid=CS-ZC-FT-analyst_blog|company_news_-_medical_sector-2200585
Dec 20, 2023 - Gilead (GILD) enters into a license agreement with Compugen for its pre-clinical immunotherapy program.
0